Unique Ingredient Identifier 3NXW29V3WO is listed as a unspecified ingredient
| RN | 9004-65-3 |
| NCIT | C80902 |
| RXCUI | 27334 |
| INN ID | 2412 |
| MF | Polymer substance not supported |
UNII 3NXW29V3WO HYPROMELLOSE, UNSPECIFIED is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| ORAL | CAPSULE | 113.6577 MG |
| ORAL | TABLET | 21.8 mg |
| BUCCAL | TABLET | 24 MG |
| INHALATION | POWDER | 45.67 MG |
| IRRIGATION | SOLUTION | NA |
| NASAL | POWDER, FOR INHALATION | NA |
| NASAL | SOLUTION, SPRAY | 0.1 % |
| NASAL | SOLUTION, SPRAY, METERED, PUMP | 0.014 % |
| NASAL | SPRAY | 0.1 % |
| NASAL | SPRAY, METERED | 0.1 % |
| OPHTHALMIC | GEL | 2.25 % |
| OPHTHALMIC | SOLUTION | 0.5 % |
| OPHTHALMIC | SOLUTION, DROPS | 0.5 % |
| OPHTHALMIC | SOLUTION/DROPS | 0.5 % |
| OPHTHALMIC | SUSPENSION | 0.5 % |
| OPHTHALMIC | SUSPENSION, DROPS | 0.6 % |
| ORAL | CAPSULE | 155 MG |
| ORAL | CAPSULE, COATED PELLETS | 3.32 MG |
| ORAL | CAPSULE, DELAYED ACTION | 67.87 MG |
| ORAL | CAPSULE, DELAYED ACTION, COATED, HARD GELATIN | 20 MG |
| ORAL | CAPSULE, DELAYED ACTION, ENTERIC COATED | NA |
| ORAL | CAPSULE, DELAYED RELEASE | 96 MG |
| ORAL | CAPSULE, ENTERIC COATED PELLETS | 64.43 MG |
| ORAL | CAPSULE, EXTENDED RELEASE | 118 MG |
| ORAL | CAPSULE, HARD GELATIN | 73.9 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 118 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 670.04 MG |
| ORAL | CONCENTRATE | NA |
| ORAL | DROPS | 1.3 MG/1ML |
| ORAL | FILM, SOLUBLE | 33.5 MG |
| ORAL | GRANULE | NA |
| ORAL | GRANULE, ENTERIC COATED | 17.2 MG |
| ORAL | GRANULE, FOR ORAL SUSPENSION | 10.6 MG |
| ORAL | PELLET | 6.7 MG |
| ORAL | POWDER, FOR ORAL SUSPENSION | 75 MG/5ML |
| ORAL | POWDER, FOR RECONSTITUTION | 150 MG/5ML |
| ORAL | POWDER, FOR SUSPENSION | 65 MG/5ML |
| ORAL | SOLUTION | 4.5 MG/1ML |
| ORAL | SUSPENSION | 325 MG/5ML |
| ORAL | SUSPENSION, LIQUID | 5 MG/1ML |
| ORAL | SYRUP | 180 MG/5ML |
| ORAL | TABLET | 16.68 mg |
| ORAL | TABLET (IMMED./COMP. RELEASE), COATED | 19.2 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 24 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 10 MG |
| ORAL | TABLET, CHEWABLE | 22 MG |
| ORAL | TABLET, COATED | 245 MG |
| ORAL | TABLET, CONTROLLED RELEASE | 65.7 MG |
| ORAL | TABLET, DELAYED ACTION | 19.62 MG |
| ORAL | TABLET, DELAYED ACTION, ENTERIC COATED | 127.29 MG |
| ORAL | TABLET, DELAYED RELEASE | 16.4 MG |
| ORAL | TABLET, EXTENDED RELEASE | 450 MG |
| ORAL | TABLET, FILM COATED | 536.8 MG |
| ORAL | TABLET, FILM COATED, EXTENDED RELEASE | 48.01 MG |
| ORAL | TABLET, FOR SUSPENSION | 45 MG |
| ORAL | TABLET, MULTILAYER, EXTENDED RELEASE | 125.5 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING | 18 MG |
| ORAL | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE | 29 MG |
| ORAL | TABLET, SUSTAINED ACTION | 400 MG |
| ORAL | TABLET, SUSTAINED ACTION, COATED | 221 MG |
| ORAL | TABLET, SUSTAINED ACTION, FILM COATED | 58.33 MG |
| ORAL | TABLET, SUSTAINED RELEASE, FILM COATED | 300 MG |
| RECTAL | GEL | 8.7 % |
| TOPICAL | EMULSION, CREAM | 0.1 %W/W |
| TOPICAL | EMULSION, LOTION | 0.1 %W/W |
| TOPICAL | JELLY | 2.5 %W/W |
| TOPICAL | LOTION | 0.1 %W/W |
| TOPICAL | PATCH | NA |
| TOPICAL | SOLUTION | 4 %W/V |
| TOPICAL | SOLUTION, DROPS | 0.11 %W/V |
| URETHRAL | JELLY | 2.3 % |
| VAGINAL | GEL | 3.5 % |
| VAGINAL | INSERT | 52.6 MG |
| VAGINAL | TABLET | 5 MG |
| VAGINAL | TABLET, FILM COATED | 54.21 MG |
| ORAL | TABLET, FILM COATED | 9.6 mg |